Contribution: Industrial Research Assistance Program – Contributions to Firms
iProgen Biotech Inc.
$853,470.00
UKRI Biomanufacturing - 10098388 ADC Biocomputer - Development of Automated and Computerized Antibody Drug Conjugate Biomanufacturing Device
EF 2023-24 · 2024-03-01
Résumé
As part of the international consortium project ADC Biocomputer, this project will focus on the development of an advanced, customizable, automated Antibody Drug Conjugate (ADC) biomanufacturing device.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Burnaby|Burnaby, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
826908816
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2026-03-01
Agreement Number
1016660
Agreement Start Date
2024-03-01
Agreement Title
UKRI Biomanufacturing - 10098388 ADC Biocomputer - Development of Automated and Computerized Antibody Drug Conjugate Biomanufacturing Device
Agreement Title (French)
UKRI Biofabrication - 10098388 ADC Biocomputer - Développement d’un dispositif automatisé et informatisé de biofabrication d’anticorps conjugués à des médicaments
Agreement Type
Contribution
Agreement Value
$853,470.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
As part of the international consortium project ADC Biocomputer, this project will focus on the development of an advanced, customizable, automated Antibody Drug Conjugate (ADC) biomanufacturing device.
Description (French)
Dans le cadre du projet de consortium international ADC Biocomputer, ce projet se concentrera sur le développement d’un dispositif avancé, personnalisable et automatisé de bioproduction de conjugués d’anticorps (ADC).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burnaby North--Seymour
Federal Riding (French)
Burnaby-Nord--Seymour
Federal Riding Number
59002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
826908816
Recipient City
Burnaby|Burnaby
Recipient Country
CA
Recipient Legal Name
iProgen Biotech Inc.
Recipient Postal Code
V5A 4N4
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2023-2024-Q4-1016660
